UROONCRX ONSITE PRECISION RADIOPHARMACY
Live / Applied — Statement of use — processing complete, to examiner (as of 27 Oct 2026)
What this means for you
Not registered yet, but its 05 Jun 2025 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 99219413
- Mark type
- Design + words
- Filed
- 05 Jun 2025
- Published for opposition
- 17 Feb 2026
- Attorney of record
- Andrew S. Ehard
Goods and services
- Class 040 — Treatment of materials: Custom manufacture of radiopharmaceuticals to order or specification of others
- Class 041 — Education and entertainment services: Training services in the use and administration of radiopharmaceuticals
- Class 045 — Legal and security services: Regulatory compliance consultancy services in the medical field
Owner
- Telix Pharmaceuticals Limited, North Melbourne, VIC, AU
- Telix Pharmaceuticals Limited, North Melbourne, VIC, AU
Prosecution history
- 27 Oct 2026 — STATEMENT OF USE PROCESSING COMPLETE
- 22 Oct 2026 — USE AMENDMENT FILED
- 22 Oct 2026 — TEAS STATEMENT OF USE RECEIVED
- 15 Oct 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 14 Oct 2026 — SOU EXTENSION 1 GRANTED
- 14 Oct 2026 — SOU EXTENSION 1 FILED
- 14 Oct 2026 — SOU TEAS EXTENSION RECEIVED
- 14 Jun 2026 — ASSIGNED TO EXAMINER
- 14 Apr 2026 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 17 Feb 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 17 Feb 2026 — PUBLISHED FOR OPPOSITION
- 11 Feb 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 24 Jan 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 02 Dec 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 02 Dec 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE